Laboratory Systems As an Antibacterial Resistance Containment Tool in Africa

Overview

Journal Afr J Lab Med

Date 2017 Sep 8

PMID 28879140

Citations 6

Authors

Iruka N Okeke

Affiliations

Soon will be listed here.

Abstract

Introduction: As crucial as clinical laboratories are to preventing, identifying and managing resistance problems, laboratory scientists are among the most overlooked stakeholders. This review outlines the contributions that diagnostic laboratory systems should make toward all five of the World Health Organization's 2015 strategic objectives for antimicrobial resistance containment.

Laboratory Systems In Resistance Containment: Antimicrobial susceptibility testing and surveillance are central to antibacterial resistance management and control and need to be implemented more commonly and closer to sick patients. However, the scope of tests that promote judicious antimicrobial use extend beyond susceptibility testing. Laboratory tests for pathogens or their associated biomarkers confirm or rule out specific causes of signs and symptoms associated with infection. Laboratory systems also provide critical support to infection control programmes. All of these functions promote rational antimicrobial use and contain the spread of resistance. Routine laboratory data supports the development of vaccines and other technologies that could ease the pressure placed by antimicrobials. Laboratories are also a rich source of information for health professionals, policymakers and the general public about the urgency of the resistance problem and progress in containing it.

Conclusion: Laboratory systems are integral to antimicrobial resistance containment and contributions from African laboratories to addressing resistance need to be enhanced.

Citing Articles

Prescribing patterns of antimicrobials according to the WHO AWaRe classification at a tertiary referral hospital in the southern highlands of Tanzania.

Nsojo A, George L, Mwasomola D, Tawete J, Mbotwa C, Mweya C Infect Prev Pract. 2024; 6(2):100347.

PMID: 38405014 PMC: 10883815. DOI: 10.1016/j.infpip.2024.100347.

Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states.

Vounba P, Loul S, Tamadea L, Siawaya J Afr J Lab Med. 2022; 11(1):1570.

PMID: 35402201 PMC: 8991180. DOI: 10.4102/ajlm.v11i1.1570.

Blood culture surveillance in a secondary care hospital in Benin: epidemiology of bloodstream infection pathogens and antimicrobial resistance.

Ombelet S, Kpossou G, Kotchare C, Agbobli E, Sogbo F, Massou F BMC Infect Dis. 2022; 22(1):119.

PMID: 35114948 PMC: 8812239. DOI: 10.1186/s12879-022-07077-z.

Using treatment guidelines to improve antibiotic use: insights from an antibiotic point prevalence survey in Kenya.

Maina M, Mcknight J, Tosas-Auguet O, Schultsz C, English M BMJ Glob Health. 2021; 6(1).

PMID: 33419928 PMC: 7798408. DOI: 10.1136/bmjgh-2020-003836.

Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana's success story.

Opintan J Afr J Lab Med. 2018; 7(2):825.

PMID: 30568905 PMC: 6295982. DOI: 10.4102/ajlm.v7i2.825.

References

Ayanruoh S, Waseem M, Quee F, Humphrey A, Reynolds T . Impact of rapid streptococcal test on antibiotic use in a pediatric emergency department. Pediatr Emerg Care. 2009; 25(11):748-50. DOI: 10.1097/PEC.0b013e3181bec88c. View

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C . High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993; 341(8844):515-8. PMC: 7141580. DOI: 10.1016/0140-6736(93)90277-n. View

Aboderin O, Adefehinti O, Odetoyin B, Olotu A, Okeke I, Adeodu O . Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing infection in Nigeria. Afr J Lab Med. 2017; 1(1):16. PMC: 5644516. DOI: 10.4102/ajlm.v1i1.16. View

Feasey N, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L . A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out. PLoS One. 2014; 9(3):e92226. PMC: 3958486. DOI: 10.1371/journal.pone.0092226. View

Eber M, Laxminarayan R, Perencevich E, Malani A . Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med. 2010; 170(4):347-53. DOI: 10.1001/archinternmed.2009.509. View

Polage C, Bedu-Addo G, Owusu-Ofori A, Frimpong E, Lloyd W, Zurcher E . Laboratory use in Ghana: physician perception and practice. Am J Trop Med Hyg. 2006; 75(3):526-31. View

Lamikanra A, Crowe J, Lijek R, Odetoyin B, Wain J, Aboderin A . Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use. BMC Infect Dis. 2011; 11:312. PMC: 3226678. DOI: 10.1186/1471-2334-11-312. View

Petti C, Polage C, Quinn T, Ronald A, Sande M . Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006; 42(3):377-82. DOI: 10.1086/499363. View

Goossens H . European status of resistance in nosocomial infections. Chemotherapy. 2005; 51(4):177-81. DOI: 10.1159/000086919. View

10.

Ericsson H, SHERRIS J . Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971; 217:Suppl 217:1+. View

11.

Gandhi N, Moll A, Sturm A, Pawinski R, Govender T, Lalloo U . Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368(9547):1575-80. DOI: 10.1016/S0140-6736(06)69573-1. View

12.

Hanage W, Finkelstein J, Huang S, Pelton S, Stevenson A, Kleinman K . Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics. 2010; 2(2):80-4. PMC: 2963072. DOI: 10.1016/j.epidem.2010.03.005. View

13.

Koser C, Ellington M, Cartwright E, Gillespie S, Brown N, Farrington M . Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog. 2012; 8(8):e1002824. PMC: 3410874. DOI: 10.1371/journal.ppat.1002824. View

14.

OBrien T, Stelling J . WHONET: an information system for monitoring antimicrobial resistance. Emerg Infect Dis. 1995; 1(2):66. PMC: 2626837. DOI: 10.3201/eid0102.950209. View

15.

Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

16.

Earnshaw S, Monnet D, Duncan B, OToole J, Ekdahl K, Goossens H . European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill. 2009; 14(30):19280. DOI: 10.2807/ese.14.30.19280-en. View

17.

Castro-Sanchez E, Chang P, Vila-Candel R, Escobedo A, Holmes A . Health literacy and infectious diseases: why does it matter?. Int J Infect Dis. 2016; 43:103-110. DOI: 10.1016/j.ijid.2015.12.019. View

18.

Boehme C, Nabeta P, Hillemann D, Nicol M, Shenai S, Krapp F . Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363(11):1005-15. PMC: 2947799. DOI: 10.1056/NEJMoa0907847. View

19.

Grundmann H, Aanensen D, van den Wijngaard C, Spratt B, Harmsen D, Friedrich A . Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 2010; 7(1):e1000215. PMC: 2796391. DOI: 10.1371/journal.pmed.1000215. View

20.

Mendelson M, Matsoso M . The World Health Organization Global Action Plan for antimicrobial resistance. S Afr Med J. 2015; 105(5):325. DOI: 10.7196/samj.9644. View